Table 2.
Development Cohort | Validation Cohort | P Valuea | Total Cohort | ||||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Demographics | |||||||
Number | 48,840 | 24,416 | 73,256 | ||||
Age, years | |||||||
65-69 | 9,259 | 19.0 | 4,694 | 19.2 | 0.1925 | 13,953 | 19.0 |
70-74 | 12,500 | 25.6 | 6,378 | 26.1 | 18,878 | 25.8 | |
75-79 | 11,796 | 24.2 | 5,722 | 23.4 | 17,518 | 23.9 | |
80-84 | 9,752 | 20.0 | 4,885 | 20.0 | 14,637 | 20.0 | |
85-89 | 5,533 | 11.3 | 2,737 | 11.2 | 8,270 | 11.3 | |
Mean (SD) | 76.0 (6.3) | 75.9 (6.3) | 0.1864 | 76.0 (6.3) | |||
Median [range] | 76 [65-89] | 75 [65-89] | 76 [65-89] | ||||
Gender | |||||||
Male | 20,887 | 42.8 | 10,282 | 42.1 | 0.0913 | 31,169 | 42.5 |
Female | 27,953 | 57.2 | 14,134 | 57.9 | 42,087 | 57.5 | |
Race/ethnicity | |||||||
Caucasian | 34,290 | 70.2 | 17,045 | 69.8 | 0.1796 | 51,335 | 70.1 |
African American | 11,118 | 22.8 | 5,668 | 23.2 | 16,786 | 22.9 | |
Hispanic | 1,956 | 4.0 | 1,014 | 4.2 | 2,970 | 4.1 | |
Other/unknown | 1,476 | 3.0 | 689 | 2.8 | 2,165 | 3.0 | |
Geographic region | |||||||
Northeast | 783 | 1.6 | 396 | 1.6 | 0.9970 | 1,179 | 1.6 |
Midwest | 9,705 | 19.9 | 4,848 | 19.9 | 14,553 | 19.9 | |
South | 34,611 | 70.9 | 17,296 | 70.8 | 51,907 | 70.9 | |
West | 3,741 | 7.7 | 1,876 | 7.7 | 5,617 | 7.7 | |
Plan type | |||||||
HMO | 26,317 | 53.9 | 12,992 | 53.2 | 0.1621 | 39,309 | 53.7 |
PPO | 13,837 | 28.3 | 6,966 | 28.5 | 20,803 | 28.4 | |
Other | 8,686 | 17.8 | 4,458 | 18.3 | 13,144 | 17.9 | |
Low-income subsidy | 7,753 | 15.9 | 3,971 | 16.3 | 0.1751 | 11,724 | 16.0 |
Medical Characteristics | |||||||
Comorbidities | |||||||
Chronic conditions | |||||||
Hypertension | 35,346 | 72.4 | 17,761 | 72.7 | 0.2875 | 53,107 | 72.5 |
Hyperlipidemia | 33,086 | 67.7 | 16,604 | 68.0 | 0.4760 | 49,690 | 67.8 |
Diabetes | 17,235 | 35.3 | 8,752 | 35.8 | 0.1377 | 25,987 | 35.5 |
Congestive heart failure | 3,342 | 6.8 | 1,642 | 6.7 | 0.5511 | 4,984 | 6.8 |
Physical/mental disabilities | |||||||
Joint disorders | 7,489 | 15.3 | 3,796 | 15.5 | 0.4506 | 11,285 | 15.4 |
Muscle weakness/neuropathy/movement disorders | 5,472 | 11.2 | 2,773 | 11.4 | 0.5358 | 8,245 | 11.3 |
Mental disorders | 4,826 | 9.9 | 2,547 | 10.4 | 0.0196 | 7,373 | 10.1 |
Glaucoma-related measures | |||||||
Glaucoma diagnosis | 40,347 | 82.6 | 20,237 | 82.9 | 0.3560 | 60,584 | 82.7 |
Open-angle glaucoma diagnosis (by an ophthalmologist) | 26,965 | 55.2 | 13,659 | 55.9 | 0.0603 | 40,624 | 55.5 |
Glaucoma-related eye exam | 24,975 | 51.1 | 12,526 | 51.3 | 0.6717 | 37,501 | 51.2 |
Glaucoma surgery | 1,612 | 3.3 | 807 | 3.3 | 0.9736 | 2,419 | 3.3 |
Other | |||||||
Number of physicians seen, mean (SD) | 8.6 (6.5) | 8.8 (6.5) | 0.0080 | 8.7 (6.5) | |||
Median [range] | 7 [0-84] | 8 [0-72] | 8 [0-84] | ||||
Medical costs per member, mean (SD) | $5,332 ($11,062) | $5,470 ($11,315) | 0.0043 | $5,378 ($11,147) | |||
Median [range] | $1,988 [$0-$310,074] | $2,061 [$0-$382,728] | $2,013 [$0-$382,728] | ||||
Pharmacy Characteristics | |||||||
New (vs. continuing) user | 14,930 | 30.6 | 7,439 | 30.5 | 0.7786 | 22,369 | 30.5 |
Mail order (index script) | 16,950 | 34.7 | 8,518 | 34.9 | 0.6262 | 25,468 | 34.8 |
Pharmacy Characteristics | |||||||
Source of index prescription | |||||||
Written | 23,747 | 48.6 | 11,898 | 48.7 | 0.6175 | 35,645 | 48.7 |
Electronic | 11,807 | 24.2 | 5,789 | 23.7 | 17,596 | 24.0 | |
Phone | 5,012 | 10.3 | 2,516 | 10.3 | 7,528 | 10.3 | |
Fax | 7,912 | 16.2 | 4,012 | 16.4 | 11,924 | 16.3 | |
Other | 362 | 0.7 | 201 | 0.8 | 563 | 0.8 | |
Formulary tier (index prescription) | |||||||
Tier 1 | 6,581 | 13.5 | 3,297 | 13.5 | 0.9860 | 9,878 | 13.5 |
Tier 2 | 34,222 | 70.1 | 17,120 | 70.1 | 51,342 | 70.1 | |
Other | 8,037 | 16.5 | 3,999 | 16.4 | 12,036 | 16.4 | |
Prescriber specialty (index prescription) | |||||||
Ophthalmologist | 31,291 | 64.1 | 15,621 | 64.0 | 0.9834 | 46,912 | 64.0 |
Optometrist | 8,238 | 16.9 | 4,133 | 16.9 | 12,371 | 16.9 | |
Family practitioner/internal medicine | 2,059 | 4.2 | 1,020 | 4.2 | 3,079 | 4.2 | |
Other/unknown | 7,252 | 14.8 | 3,642 | 14.9 | 10,894 | 14.9 | |
Prescriber gender (index prescription) | |||||||
Male | 31,947 | 65.4 | 15,944 | 65.3 | 0.4559 | 47,891 | 65.4 |
Female | 7,096 | 14.5 | 3,491 | 14.3 | 10,587 | 14.5 | |
Unknown | 9,797 | 20.1 | 4,981 | 20.4 | 14,778 | 20.2 | |
Rx-Risk-V score, mean (SD) | 6.0 (2.9) | 6.0 (2.9) | 0.0718 | 6.0 (2.9) | |||
Median [range] | 6 [1-20] | 6 [1-20] | 6 [1-20] | ||||
Number of pharmacies visited, mean (SD) | 2.1 (1.1) | 2.1 (1.1) | 0.5577 | 2.1 (1.1) | |||
Median [range] | 2 [1-25] | 2 [1-12] | 2 [1-25] | ||||
Pharmacy costs, mean (SD) | $2,439 ($3,126) | $2,460 ($3,165) | 0.1736 | $2,446 ($3,139) | |||
Median [range] | $1,809 [$4-$160,243] | $1,828 [$4-$121,051] | $1,816 [$4-160,243] |
aCalculated using an omnibus chi-square test for categorical variables, a t-test for continuous variables except costs, and a nonparametric test for costs. HMO = health maintenance organization; PPO = preferred provider organization; SD = standard deviation.